Does maternal body mass index influence treatment effect in women with mild gestational diabetes?

Brian M. Casey, Lisa Mele, Mark B. Landon, Catherine Y. Spong, Susan M. Ramin, Ronald J. Wapner, Michael W. Varner, Dwight J. Rouse, John M. Thorp, Patrick Catalano, Margaret Harper, George Saade, Yoram Sorokin, Alan M. Peaceman

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

OBJECTIVE: The aim of the article is to determine whether maternal body mass index (BMI) influences the beneficial effects of diabetes treatment in women with gestational diabetes mellitus (GDM).

STUDY DESIGN: Secondary analysis of a multicenter randomized treatment trial of women with GDM. Outcomes of interest were elevated umbilical cord c-peptide levels (> 90th percentile 1.77 ng/mL), large for gestational age (LGA) birth weight (> 90th percentile), and neonatal fat mass (g). Women were grouped into five BMI categories adapted from the World Health Organization International Classification of normal, overweight, and obese adults. Outcomes were analyzed according to treatment group assignment.

RESULTS: A total of 958 women were enrolled (485 treated and 473 controls). Maternal BMI at enrollment was not related to umbilical cord c-peptide levels. However, treatment of women in the overweight, Class I, and Class II obese categories was associated with a reduction in both LGA birth weight and neonatal fat mass. Neither measure of excess fetal growth was reduced with treatment in normal weight (BMI < 25 kg/m(2)) or Class III (BMI ≥ 40 kg/m(2)) obese women.

CONCLUSION: There was a beneficial effect of treatment on fetal growth in women with mild GDM who were overweight or Class I and Class II obese. These effects were not apparent for normal weight and very obese women.

Original languageEnglish (US)
Pages (from-to)93-100
Number of pages8
JournalAmerican Journal of Perinatology
Volume32
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Gestational Diabetes
Body Mass Index
Mothers
Umbilical Cord
Therapeutics
Fetal Development
Birth Weight
Gestational Age
Fats
Weights and Measures
Peptides

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Casey, B. M., Mele, L., Landon, M. B., Spong, C. Y., Ramin, S. M., Wapner, R. J., ... Peaceman, A. M. (2015). Does maternal body mass index influence treatment effect in women with mild gestational diabetes? American Journal of Perinatology, 32(1), 93-100. https://doi.org/10.1055/s-0034-1374815

Does maternal body mass index influence treatment effect in women with mild gestational diabetes? / Casey, Brian M.; Mele, Lisa; Landon, Mark B.; Spong, Catherine Y.; Ramin, Susan M.; Wapner, Ronald J.; Varner, Michael W.; Rouse, Dwight J.; Thorp, John M.; Catalano, Patrick; Harper, Margaret; Saade, George; Sorokin, Yoram; Peaceman, Alan M.

In: American Journal of Perinatology, Vol. 32, No. 1, 01.01.2015, p. 93-100.

Research output: Contribution to journalArticle

Casey, BM, Mele, L, Landon, MB, Spong, CY, Ramin, SM, Wapner, RJ, Varner, MW, Rouse, DJ, Thorp, JM, Catalano, P, Harper, M, Saade, G, Sorokin, Y & Peaceman, AM 2015, 'Does maternal body mass index influence treatment effect in women with mild gestational diabetes?', American Journal of Perinatology, vol. 32, no. 1, pp. 93-100. https://doi.org/10.1055/s-0034-1374815
Casey, Brian M. ; Mele, Lisa ; Landon, Mark B. ; Spong, Catherine Y. ; Ramin, Susan M. ; Wapner, Ronald J. ; Varner, Michael W. ; Rouse, Dwight J. ; Thorp, John M. ; Catalano, Patrick ; Harper, Margaret ; Saade, George ; Sorokin, Yoram ; Peaceman, Alan M. / Does maternal body mass index influence treatment effect in women with mild gestational diabetes?. In: American Journal of Perinatology. 2015 ; Vol. 32, No. 1. pp. 93-100.
@article{5129267662264da6adaf356ecbeb7b1b,
title = "Does maternal body mass index influence treatment effect in women with mild gestational diabetes?",
abstract = "OBJECTIVE: The aim of the article is to determine whether maternal body mass index (BMI) influences the beneficial effects of diabetes treatment in women with gestational diabetes mellitus (GDM).STUDY DESIGN: Secondary analysis of a multicenter randomized treatment trial of women with GDM. Outcomes of interest were elevated umbilical cord c-peptide levels (> 90th percentile 1.77 ng/mL), large for gestational age (LGA) birth weight (> 90th percentile), and neonatal fat mass (g). Women were grouped into five BMI categories adapted from the World Health Organization International Classification of normal, overweight, and obese adults. Outcomes were analyzed according to treatment group assignment.RESULTS: A total of 958 women were enrolled (485 treated and 473 controls). Maternal BMI at enrollment was not related to umbilical cord c-peptide levels. However, treatment of women in the overweight, Class I, and Class II obese categories was associated with a reduction in both LGA birth weight and neonatal fat mass. Neither measure of excess fetal growth was reduced with treatment in normal weight (BMI < 25 kg/m(2)) or Class III (BMI ≥ 40 kg/m(2)) obese women.CONCLUSION: There was a beneficial effect of treatment on fetal growth in women with mild GDM who were overweight or Class I and Class II obese. These effects were not apparent for normal weight and very obese women.",
author = "Casey, {Brian M.} and Lisa Mele and Landon, {Mark B.} and Spong, {Catherine Y.} and Ramin, {Susan M.} and Wapner, {Ronald J.} and Varner, {Michael W.} and Rouse, {Dwight J.} and Thorp, {John M.} and Patrick Catalano and Margaret Harper and George Saade and Yoram Sorokin and Peaceman, {Alan M.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1055/s-0034-1374815",
language = "English (US)",
volume = "32",
pages = "93--100",
journal = "American Journal of Perinatology",
issn = "0735-1631",
publisher = "Thieme Medical Publishers",
number = "1",

}

TY - JOUR

T1 - Does maternal body mass index influence treatment effect in women with mild gestational diabetes?

AU - Casey, Brian M.

AU - Mele, Lisa

AU - Landon, Mark B.

AU - Spong, Catherine Y.

AU - Ramin, Susan M.

AU - Wapner, Ronald J.

AU - Varner, Michael W.

AU - Rouse, Dwight J.

AU - Thorp, John M.

AU - Catalano, Patrick

AU - Harper, Margaret

AU - Saade, George

AU - Sorokin, Yoram

AU - Peaceman, Alan M.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - OBJECTIVE: The aim of the article is to determine whether maternal body mass index (BMI) influences the beneficial effects of diabetes treatment in women with gestational diabetes mellitus (GDM).STUDY DESIGN: Secondary analysis of a multicenter randomized treatment trial of women with GDM. Outcomes of interest were elevated umbilical cord c-peptide levels (> 90th percentile 1.77 ng/mL), large for gestational age (LGA) birth weight (> 90th percentile), and neonatal fat mass (g). Women were grouped into five BMI categories adapted from the World Health Organization International Classification of normal, overweight, and obese adults. Outcomes were analyzed according to treatment group assignment.RESULTS: A total of 958 women were enrolled (485 treated and 473 controls). Maternal BMI at enrollment was not related to umbilical cord c-peptide levels. However, treatment of women in the overweight, Class I, and Class II obese categories was associated with a reduction in both LGA birth weight and neonatal fat mass. Neither measure of excess fetal growth was reduced with treatment in normal weight (BMI < 25 kg/m(2)) or Class III (BMI ≥ 40 kg/m(2)) obese women.CONCLUSION: There was a beneficial effect of treatment on fetal growth in women with mild GDM who were overweight or Class I and Class II obese. These effects were not apparent for normal weight and very obese women.

AB - OBJECTIVE: The aim of the article is to determine whether maternal body mass index (BMI) influences the beneficial effects of diabetes treatment in women with gestational diabetes mellitus (GDM).STUDY DESIGN: Secondary analysis of a multicenter randomized treatment trial of women with GDM. Outcomes of interest were elevated umbilical cord c-peptide levels (> 90th percentile 1.77 ng/mL), large for gestational age (LGA) birth weight (> 90th percentile), and neonatal fat mass (g). Women were grouped into five BMI categories adapted from the World Health Organization International Classification of normal, overweight, and obese adults. Outcomes were analyzed according to treatment group assignment.RESULTS: A total of 958 women were enrolled (485 treated and 473 controls). Maternal BMI at enrollment was not related to umbilical cord c-peptide levels. However, treatment of women in the overweight, Class I, and Class II obese categories was associated with a reduction in both LGA birth weight and neonatal fat mass. Neither measure of excess fetal growth was reduced with treatment in normal weight (BMI < 25 kg/m(2)) or Class III (BMI ≥ 40 kg/m(2)) obese women.CONCLUSION: There was a beneficial effect of treatment on fetal growth in women with mild GDM who were overweight or Class I and Class II obese. These effects were not apparent for normal weight and very obese women.

UR - http://www.scopus.com/inward/record.url?scp=84983738779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983738779&partnerID=8YFLogxK

U2 - 10.1055/s-0034-1374815

DO - 10.1055/s-0034-1374815

M3 - Article

C2 - 24839145

AN - SCOPUS:84900352878

VL - 32

SP - 93

EP - 100

JO - American Journal of Perinatology

JF - American Journal of Perinatology

SN - 0735-1631

IS - 1

ER -